Ehmer Bernhard
Chairman of the Board of directors,
Department of Dermatology
JDeck Inc
Austria
Biography
Bernhard Ehmer is chairman of the Board of management of Biotest AG since January 2015. Prior to this he worked for the Imclone Group, a wholly owned subsidiary of Eli Lilly as president of Imclone Systems Corporation in the US and as managing director in Germany. 2007/2008 he was CEO of Fresenius Biotech, Germany. From 2000 until 2005 Bernhard Ehmer headed the Business Area Oncology of Merck KgaA, Darmstadt - from 1998 until 2000 he was head of "Global Clinical Operations" at Merck. Between 1986 and 1998 he held various functions at Boehringer Mannheim in Germany, Italy and Singapore. Bernhard Ehmer holds a degree in medicine and worked in Internal Medicine at the Academic Teaching Hospital of the University of Heidelberg with focus on Cardiology/Intensive Care until he joined the pharmaceutical industry in 1986. Dr. Bernhard Ehmer was born in 1955.
Research Interest
Research, Pharmaceuticals, Biotechnology, Healthcare, Medical Science
